Latest filing published 11 Sept 2026 for Tenaya Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Faraz Ali on record concern Tenaya Therapeutics, Inc. Between 15 February 2023 and 10 September 2026, the trades on record add up to 20 filings.
Every open-market trade on record is a sale: 15 sales worth €107k. Other entries cover 5 share grants. 2026 to date brings no purchases and 8 sales.
The latest filing, published on 11 September 2026, reports a share grant in Tenaya Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations